These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26295952)

  • 21. Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation.
    Kim SK; Vaishali B; Lee E; Lee S; Lee YK; Kumar TS; Moon HT; Byun Y
    Thromb Res; 2006; 117(4):419-27. PubMed ID: 15913716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin--a key drug in the treatment of the circulatory degenerative diseases: controlling its action with polymers.
    Szczubiałka K; Kamiński K; Zasada K; Karewicz A; Nowakowska M
    Curr Pharm Des; 2012; 18(18):2591-606. PubMed ID: 22512445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent Advances in Non-Invasive Delivery of Macromolecules using Nanoparticulate Carriers System.
    Shadab M; Haque S; Sheshala R; Meng LW; Meka VS; Ali J
    Curr Pharm Des; 2017; 23(3):440-453. PubMed ID: 27784250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin.
    Chen MC; Wong HS; Lin KJ; Chen HL; Wey SP; Sonaje K; Lin YH; Chu CY; Sung HW
    Biomaterials; 2009 Dec; 30(34):6629-37. PubMed ID: 19767097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal delivery of heparin: Physical enhancement techniques.
    Ita K
    Int J Pharm; 2015 Dec; 496(2):240-9. PubMed ID: 26611668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel delivery systems for anti-allergic agents: allergic disease and innovative treatments.
    Lopes CM; Coelho PB; Oliveira R
    Curr Drug Deliv; 2015; 12(4):382-96. PubMed ID: 25895551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodegradable Ingredient-Based Emulgel Loaded with Ketoprofen Nanoparticles.
    Gul R; Ahmed N; Ullah N; Khan MI; Elaissari A; Rehman AU
    AAPS PharmSciTech; 2018 May; 19(4):1869-1881. PubMed ID: 29651679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
    Wen MM; Farid RM; Kassem AA
    J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of preparation parameters on typical attributes of chitosan-heparin nanohydrogels: particle size, loading efficiency, and drug release.
    Shahbazi MA; Hamidi M
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1774-82. PubMed ID: 23136990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic optimisation of the treatment of deep vein thrombosis.
    Iorio A; Agnelli G
    Clin Pharmacokinet; 1997 Feb; 32(2):145-72. PubMed ID: 9068929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulant efficacy of solid oral formulations containing a new heparin derivative.
    Park JW; Jeon OC; Kim SK; Al-Hilal TA; Moon HT; Kim CY; Byun Y
    Mol Pharm; 2010 Jun; 7(3):836-43. PubMed ID: 20349950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits.
    Jiao Y; Ubrich N; Marchand-Arvier M; Vigneron C; Hoffman M; Lecompte T; Maincent P
    Circulation; 2002 Jan; 105(2):230-5. PubMed ID: 11790706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions.
    Suresh PK; Sah AK
    Expert Opin Drug Deliv; 2014 Nov; 11(11):1747-68. PubMed ID: 25007007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioactive supramolecular hydrogel with controlled dual drug release characteristics.
    Ma D; Tu K; Zhang LM
    Biomacromolecules; 2010 Sep; 11(9):2204-12. PubMed ID: 20831271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin appended ADH-anionic polysaccharide nanoparticles for site-specific delivery of usnic acid.
    Garg A; Garg S; Sahu NK; Rani S; Gupta U; Yadav AK
    Int J Pharm; 2019 Feb; 557():238-253. PubMed ID: 30594688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low molecular weight heparins for current and future uses: approaches for micro- and nano-particulate delivery.
    Ibrahim SS; Osman R; Awad GA; Mortada ND; Geneidy AS
    Drug Deliv; 2016 Oct; 23(8):2661-2667. PubMed ID: 26056721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-assembling lipid modified glycol-split heparin nanoparticles suppress lipopolysaccharide-induced inflammation through TLR4-NF-κB signaling.
    Babazada H; Yamashita F; Yanamoto S; Hashida M
    J Control Release; 2014 Nov; 194():332-40. PubMed ID: 25234820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.